Went to MD Anderson for a second opinion and was sent to do more tests. If you read previous posts, my local team didn't come to any strong recommendation for the next option after completing chemotherapy. Clinical panel concluded that RP is not a good option for me and RT does not have enough evidence for my staging to strongly recommend it.
Then I met separately with onc surgeon and he suggested surgery is my best option with RT a second one. Next meeting was with the RO and he suggested that best option would be SBRT saying that he could radiate all those areas where RP would not reach.
So I went to MD Anderson and the doctor there said:
1) we don't have enough data to make any conclusions now
2) I'm clearly an outlier and median results from clinical trials should not be applied to my case. We need to figure out an individualized approach based on specific data.
So she ordered a lot more blood tests (lipid, CEA, CTC, CRP), genetic mutations and scans, specifically bone scan and CT body scan.
So I have scan results in and they suggest that there's not much metastatic activity:
CT Bone Scan:
Impression: No convincing evidence of osseous metastatic disease.
Findings: Subtle scattered foci of increased radiotracer uptake in the lumbar spine is likely secondary to degenerative changes. There are no convincing abnormalities of suspicion for osseous metastases. Physiologic activity is seen in the kidneys and bladder.
CT chest, abdomen, pelvis summary:
No evidence of lymphadenopathy in either abdomen or pelvis. The nodal disease involving the left common iliac chains and internal iliac chain have decreased in sizes significantly. The residual lymph nodes are barely appreciable, measuring approximately 4 mm at most (image #1:30, 127, series #4). No new lymph node or lymphadenopathy.
The metastatic disease at L4 is barely appreciable, probably treated or in the process of a healing. Additional healing metastasis is noted at L5 primarily involving the lateral process. No definite new metastasis to the bones.
Also CellSearch CTC came back with zero, which is encouraging but I still don't know the value of this test, some studies show correlation with prognosis. Overall it looks like things are going quite well and I'm looking forward to debriefing of the results with the new doc.